GeneDx Holdings
82 hedge funds and large institutions have $172M invested in GeneDx Holdings in 2023 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 13 reducing their positions, and 20 closing their positions.
3,623% more call options, than puts
Call options by funds: $1.15M | Put options by funds: $31K
360% more capital invested
Capital invested by funds: $37.3M → $172M (+$134M)
200% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 13
0.68% more ownership
Funds ownership: 1.11% → 1.79% (+0.68%)
5% less funds holding
Funds holding: 86 → 82 (-4)
10% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Casdin Capital
New York
|
+$34.6M |
| 2 |
CM
Corvex Management
New York
|
+$31.4M |
| 3 |
DM
Deerfield Management
New York
|
+$19M |
| 4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$9.23M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$7.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$2.68M |
| 2 |
Renaissance Technologies
New York
|
-$820K |
| 3 |
ZDA
Zweig-DiMenna Associates
New York
|
-$375K |
| 4 |
D.E. Shaw & Co
New York
|
-$172K |
| 5 |
HF
HRT Financial
New York
|
-$150K |
WGS Hedge Fund Activity: Q1 2023 in Review
82 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q1 2023, worth a combined $172M — up 360% from $37.3M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of WGS and 18 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 39 added.
The largest buyer was Casdin Capital, adding an estimated $34.6M. The largest seller was Goldman Sachs, cutting an estimated $2.68M.
- 82 institutional investors held GeneDx Holdings (WGS) as of Q1 2023, down from 86 in Q4 2022.
- Funds reported $172M of GeneDx Holdings stock for Q1 2023, up 360% quarter-over-quarter.
- 18 funds opened new GeneDx Holdings positions in Q1 2023 and 20 closed out, a net change of -2 holders.
- The largest GeneDx Holdings buyer in Q1 2023 was Casdin Capital, an estimated $34.6M added.
- The largest GeneDx Holdings seller in Q1 2023 was Goldman Sachs, an estimated $2.68M sold.
Based on aggregated 13F filings for Q1 2023.